Dyne Therapeutics
114 hedge funds and large institutions have $537M invested in Dyne Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 118 → 114 (-4)
19% less capital invested
Capital invested by funds: $666M → $537M (-$129M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
114
Holding in Top 10
3
Calls
$3.05M
Puts
$82K
Top Buyers
| 1 | +$4.1M | |
| 2 | +$3.98M | |
| 3 | +$3.58M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.01M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.71M |
Top Sellers
| 1 | -$8.99M | |
| 2 | -$5.63M | |
| 3 | -$5.12M | |
| 4 |
Goldman Sachs
New York
|
-$4.49M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.2M |